Q21IR9 AF NFT

Ubiquinone biosynthesis O-methyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicjxq3nng6gy53aixab6nndrvpguuv74gzsiwtjrfigsf6rfeetxm/metadata.json
IPFS of structure file: 
bafybeibqf5zcoezzkrq3eykngax6mwoj6czjvzoaygxxjmhqzo5hqjdfja/AF-Q21IR9-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xF24817C5206766671639b7d5b9Dca77a7dDef039
First NFT owner address (bech32): 
genesis17fyp03fqvanxw93ekl2mnh980f7aaupeyqna3d
Current NFT ID #486728 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
486728
Accession (UniProt):
Q21IR9
Name::
Ubiquinone biosynthesis O-methyltransferase
Experimental Method:
Predicted structure
Sequence source:
Saccharophagus degradans (strain 2-40 / ATCC 43961 / DSM 17024)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q21IR9 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q21IR9|UBIG_SACD2 Ubiquinone biosynthesis O-methyltransferase OS=Saccharophagus degradans (strain 2-40 / ATCC 43961 / DSM 17024) OX=203122 GN=ubiG PE=3 SV=1 MTTQELNVDSAEIAKFERLAARWWDLEGEFKPLHDLNPLRANYIDERAQVAEKKLLDVGCGGGILCEAMAQRGAIVTGIDMGDAPLEVAKLHSLESGVNVDYIKTTAEEFAAKHPQSYDVVTCLEMLEHVPDPAQTIAACAQLVKPGGDIFFSTINRNPKAYLFAVVGAEYVLKMLPKGTHDYNKFIRPSELAQWMRNAGLELQEMCGMTYNPITKHYKLNAKDVSVNYIMHARKI